- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2025
- 400 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 181 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 187 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 115 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- December 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- December 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- July 2024
- 100 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- July 2024
- 100 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- October 2024
- 93 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- December 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- December 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- May 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,208GBP
- Report
- August 2024
- 200 Pages
Global
From €3521EUR$3,869USD£2,991GBP

The Spinal Cord Stimulator (SCS) is a type of medical device used to treat chronic pain in the lower back, neck, and limbs. It works by sending electrical pulses to the spinal cord, which can help reduce pain signals sent to the brain. SCS is a form of neuromodulation, which is a type of therapy that uses electrical stimulation to modify nerve activity. It is used to treat a variety of conditions, including failed back surgery syndrome, complex regional pain syndrome, and peripheral neuropathy.
SCS is a minimally invasive procedure, and is typically used when other treatments have failed. It is typically implanted in the lower back, and is connected to a small battery-powered device that is worn externally. The device is programmed to deliver electrical pulses to the spinal cord, which can help reduce pain signals sent to the brain.
The SCS market is a growing segment of the neurology devices market. It is expected to continue to grow as more patients seek out minimally invasive treatments for chronic pain.
Some companies in the SCS market include Medtronic, Boston Scientific, St. Jude Medical, and Nevro. Show Less Read more